Clearmind Medicine CMND
NASDAQ CMND
$1.78 +0.05 (+3.19%)
As of: Aug 21, 2026 · 1:20 PM EDT

Clearmind Medicine (CMND) EPS (Diluted) (2022 - 2026)

Clearmind Medicine (CMND) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.90 Bn 131.05 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 86.10 Bn 78.11 Bn 3.93 Bn 12.23
3 Argenx Se 65.56 Bn 60.37 Bn 1.37 Bn 7.33
4 Moderna 55.82 Bn 50.68 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.14 Bn 37.04 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 1.19
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn -0.72
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.38 Bn 26.54 Bn - 0.15
10 Clearmind Medicine 537,495.91 -13.06 Mn - -6.76

Historic Data

Download Data
DateValue
Apr 30, 2026 -6.76
Jan 31, 2026 -33.10
Oct 31, 2025 -70.41
Jul 31, 2025 -97.12
Apr 30, 2025 -58.99
Jan 31, 2025 -88.49
Oct 31, 2024 -235.41
Jul 31, 2024 -225.70
Apr 30, 2024 -102.63
Jan 31, 2024 -254.30
Oct 31, 2023 -8,101.20
Jul 31, 2023 -995.68
Apr 30, 2023 -4,874.52
Jan 31, 2023 -9,511.37
Jul 31, 2022 -13,481.93
Apr 30, 2022 -16,847.11
Jan 31, 2022 -15,884.31